The history of the erectile dysfunction drug presents a complex picture for shareholders. While the initial introduction generated substantial profits, the lapse of its exclusive rights opened the door to generic https://bookmarkextent.com/story23786397/the-copyright-and-the-pharmaceutical-industry-a-risky-bet